Hutchings, K. M., Lisabeth, E. M., Rajeswaran, W., Wilson, M. W., Sorenson, R. J., Campbell, P. L., Ruth, J. H., Amin, A., Tsou, P., Leipprandt, J. R., Olson, S. R., Wen, B., Zhao, T., Sun, D., Khanna, D., Fox, D. A., Neubig, R. R., & Larsen, S. D. (2017). pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. Bioorganic & medicinal chemistry letters, 27(8), 1744–1749. http://access.bl.uk/ark:/81055/vdc_100045163420.0x000046